Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP532155.RA3xhF5c6XhhmHahoDZdY1nO0AsfMk-cTDhoi_2I5Ynqw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP532155.RA3xhF5c6XhhmHahoDZdY1nO0AsfMk-cTDhoi_2I5Ynqw130_assertion type Assertion NP532155.RA3xhF5c6XhhmHahoDZdY1nO0AsfMk-cTDhoi_2I5Ynqw130_head.
- NP532155.RA3xhF5c6XhhmHahoDZdY1nO0AsfMk-cTDhoi_2I5Ynqw130_assertion description "[LRH-1 immunoreactivity was also detected in 28% of the ductal carcinoma in situ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP532155.RA3xhF5c6XhhmHahoDZdY1nO0AsfMk-cTDhoi_2I5Ynqw130_provenance.
- NP532155.RA3xhF5c6XhhmHahoDZdY1nO0AsfMk-cTDhoi_2I5Ynqw130_assertion evidence source_evidence_literature NP532155.RA3xhF5c6XhhmHahoDZdY1nO0AsfMk-cTDhoi_2I5Ynqw130_provenance.
- NP532155.RA3xhF5c6XhhmHahoDZdY1nO0AsfMk-cTDhoi_2I5Ynqw130_assertion SIO_000772 16427184 NP532155.RA3xhF5c6XhhmHahoDZdY1nO0AsfMk-cTDhoi_2I5Ynqw130_provenance.
- NP532155.RA3xhF5c6XhhmHahoDZdY1nO0AsfMk-cTDhoi_2I5Ynqw130_assertion wasDerivedFrom befree-2016 NP532155.RA3xhF5c6XhhmHahoDZdY1nO0AsfMk-cTDhoi_2I5Ynqw130_provenance.
- NP532155.RA3xhF5c6XhhmHahoDZdY1nO0AsfMk-cTDhoi_2I5Ynqw130_assertion wasGeneratedBy ECO_0000203 NP532155.RA3xhF5c6XhhmHahoDZdY1nO0AsfMk-cTDhoi_2I5Ynqw130_provenance.